207 related articles for article (PubMed ID: 28750922)
21. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy.
Lee JW; Kim YT; Lee SH; Son JH; Kang JW; Ryu JK; Jang DK; Paik WH; Lee BS
Gut Liver; 2018 Jan; 12(1):102-110. PubMed ID: 29069888
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
25. Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients.
Kanda M; Fujii T; Takami H; Suenaga M; Inokawa Y; Yamada S; Nakayama G; Sugimoto H; Koike M; Nomoto S; Kodera Y
Surg Today; 2014 Sep; 44(9):1692-701. PubMed ID: 24114022
[TBL] [Abstract][Full Text] [Related]
26. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
[TBL] [Abstract][Full Text] [Related]
27. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of preoperative platelet count in patients with gallbladder cancer.
Wang RT; Zhang LQ; Mu YP; Li JB; Xu XS; Pang Q; Sun LK; Zhang X; Dong SB; Wang L; Liu C
World J Gastroenterol; 2015 May; 21(17):5303-10. PubMed ID: 25954104
[TBL] [Abstract][Full Text] [Related]
29. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
Kambara Y; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Yuasa N
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1918-1924. PubMed ID: 32814681
[TBL] [Abstract][Full Text] [Related]
30. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting surgical outcome for gallbladder carcinoma.
Noshiro H; Chijiiwa K; Yamaguchi K; Shimizu S; Sugitani A; Tanaka M
Hepatogastroenterology; 2003; 50(52):939-44. PubMed ID: 12845954
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
33. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
34. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
35. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.
Nozoe T; Rikimaru T; Mori E; Okuyama T; Takahashi I
J Surg Oncol; 2006 Aug; 94(2):132-7. PubMed ID: 16847905
[TBL] [Abstract][Full Text] [Related]
36. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
[TBL] [Abstract][Full Text] [Related]
37. The use of tumor markers as predictors of prognosis in gastric cancer.
Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.
Wu XS; Shi LB; Li ML; Ding Q; Weng H; Wu WG; Cao Y; Bao RF; Shu YJ; Ding QC; Mu JS; Gu J; Dong P; Liu YB
Ann Surg Oncol; 2014 Feb; 21(2):449-57. PubMed ID: 24081806
[TBL] [Abstract][Full Text] [Related]
39. The Prognostic Relevance of Preoperative CEA and CA19-9 for Ampulla of Vater Carcinoma.
Matsui S; Yamamoto Y; Okamura Y; Ito T; Ashida R; Ohgi K; Yamada M; Otsuka S; Uesaka K; Sugiura T
Anticancer Res; 2022 Jun; 42(6):3169-3176. PubMed ID: 35641260
[TBL] [Abstract][Full Text] [Related]
40. Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up.
Lian PL; Chang Y; Xu XC; Zhao Z; Wang XQ; Xu KS
World J Gastroenterol; 2017 Aug; 23(30):5579-5588. PubMed ID: 28852317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
